ArticleScientific reports2026
Early detection of metastatic risk in primary cutaneous melanoma using weakly supervised learning.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- An integrative naturopathic oncology approach in metastatic malignant melanoma: two case reports.Frontiers in oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Early identification of melanomas with high metastatic potential is crucial for treatment planning and survival prediction. We investigated whether weakly supervised WSI-based and multimodal learning approaches can identify metastatic risk in primary cutaneous melanoma beyond current clinicopathological predictors. A total of 426 routinely stained whole-slide images (WSIs), from primary melanomas (249 metastatic and 177 non-metastatic) together with corresponding clinicopathological features, were collected and divided to training and validation, and a hold-out test set. WSIs were divided into patches and encoded using Prov-GigaPath, while clinicopathological features were converted to text embeddings using BioMedBERT. We evaluated a weakly supervised transformer-based approach for slide-level metastatic risk prediction from WSIs, both alone and in combination with clinicopathological features, and compared performance to a model based on clinicopathological features alone. Both WSI-based models achieved strong performance (AUC = 0.887 and 0.883) and higher accuracy (0.847 for both) than the clinicopathological-based model (AUC = 0.849, accuracy = 0.753). This benefit was most pronounced in T2 tumors, where early risk stratification is clinically most relevant. These findings demonstrate that weakly supervised WSI-based models capture prognostically relevant information and highlight their potential for early metastatic risk stratification in primary melanoma.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.